Tissue Repair Ltd is a clinical stage biopharmaceutical company developing an advanced wound healing technology targeting applications in the chronic wound and cosmetic procedure markets. Tissue Repair has developed a unique active ingredient that is designed for wound healing and delivered topically. The biologically active pharmaceutical ingredient behaves like a decoy cell and simulates a yeast infection resulting in the stimulation of the body’s own wound repair pathways. This active ingredient also provides a platform for the opportunity to develop a range of products that have the potential to treat a broad range of conditions across the wound care market.Responsibilities:• Analyze internal operations and identify areas of process enhancement• Develop actionable business strategies and plans that ensure alignment with short-term and long term objectives • Oversee operations, HR, and accounting, and budget for sufficient investment capital to achieve growth targets over the near term• Manage capital investment and expenses to ensure the company achieves investor targets relative to growth and profitability• Monitor performance with tracking and establish corrective measures as needed, and prepare detailed reports, both current and forecasting• Maintain and build trusted relationships with key customers, clients, partners, and stakeholders

Responsibilities:• Leading, coaching, motivating and inspiring a team of Regional Account Managers to achieve or exceed sales objectives consistent with the Australian organizations' revenue objectives• Develop and maintain a sales team culture in line with the company values: Serving patients, Acting with Integrity, Empowering People and Innovating for Solutions• In partnership with Commercial Operations, develop and implement a sales targeting model with appropriate reach and frequency metrics. Lead sales and field reporting, analysis and CRM management for Australia• Collaborate closely with Medical Affairs to ensure constructive collaboration between RAMs and Medical Science Liaisons (MSLs) in line with company-defined sales and medical accountabilities.

Responsibilities:• Set the company’s vision and ensure that it is unique and attractive to potential investors• Manage revenue, expenses and external financing to maintain the consistent growth of the business• Identify market opportunities within the pharma generics space• Develop and maintain the business plan • Engage actively with investors and potential investors to support the process of fundraising

Responsibilities:- Management of the HCP Sales Team (23 people), the Training and Development Team (3 people), and brand management of the ex-Intendis portfolio.- Overall development and implementation of the Consumer Health HCP strategy covering Dermatology, Women's and Infant Health, and Gastroenterology TAs.- Achieve agreed budgeted sales and expenditure targets/market share for all brands.- Management of inventory levels and forecasting.- Management of marketing and sales budgets (approx. $6M).- Initiate and develop relationships with Key Opinion Leaders to positively influence advocacy for Bayer products. Achievements / Acknowledgements:- Achieved market share and growth targets in each of the 5 promoted products in 2018-19 (total $120M).- Successful integration of three ex-Intendis brands from BioCSL to Bayer (2014) with an immediate and sustained increase in market share/sales of Advantan. - Launch of Iberogast (2015; ex-Steigerwald).- Nomination of Global LIFE Award (2016).

Responsibilities (similar to the role above and including the following):- Partner with new business development to prepare launch strategy for Ocean Guard (2011) and Prosomnia (2011).- Responsibility for KOL relationships across specialty groups - dermatologists, gastroenterologists, obstetricians, IVF clinicians and paediatricians.- Provide guidance on and input to the development of promotional materials. Review and, defend all promotional material in compliance with the Medicines Australia Code of Conduct and other relevant requirements.Achievements / Acknowledgements:- HCP Team winner ‘Most successful Launch of a New Product’ global award for launch of Elevit (pregnancy multivitamin) (2012).- National HCP team ranked Number 1 out of 30 pharma companies in Jan-Aug 2012 period (IMS GP Monitor).- Successful launches of Prosomnia (2011), Ocean Guard (2011) and Canesten Nailset (2012).- Sustained market share growth for key HCP-driven brands (total $75M, 2013).- Local participation in the global Bayer acquisition of Steigerwald.- Successful WA hospital tender application for Novalac Allergy.

Responsibilities (similar to the roles above and including the following):- Recruit, develop and manage the HCP Sales Team (18 people), the Training and Development Team (3 people).Achievements / Acknowledgements:- Chairperson of the Asia-Pacific Sales Managers Forum which focused on implementing Key Account Management and Selling Skills initiatives.- Successful launches of Menevit (2005), Novalac range of specialist infant formula (2006), Citracal (2008).- Sustained market share growth for key HCP-driven brands (total $45M, 2010).

Responsibilities:- Overall responsibility for regulatory/scientific resources, including budget and personnel.- Management of medical activities (including clinical trials and key opinion leaders) - Participation on ASMI and other Industry-Government committees.- Develop and deliver the medical and scientific components of training for new and existing employees.- Engage and liaise across Roche global communities and international and regional affiliates and agents . Achievements / Acknowledgements:- Chairperson of the Asia-Pacific Sales Managers Forum which focused on implementing Key Account Management and Selling Skills initiatives.- Successful launch of Elevit pregnancy supplement to key healthcare professionals

Responsibilities:- Restructure of personnel and functions with the Chemicals and Non-prescription Medicines Branch.- Departmental representation at Industry-Government meetings.- Participation on ASMI and other Industry-Government committees.Achievements / Acknowledgements:- Management of the change control processes within the Branch including establishment of an Office of Complementary Medicines, recruitment, and management of PR activities- Development, preparation and implementation of legislative amendments relevant to a new advertising regime for therapeutic goods- Introduction and launch of a new Advertising Code for the therapeutic goods industry.

Responsibilities:- Coordination of a Melbourne team in an international collaboration aimed at using gene therapy techniques to construct cancer vaccines for use in Phase I clinical trials.- Management of a team of researchers working on a range of oncology projects in collaboration with other international laboratories.Achievements / Acknowledgements:- Listed as a discoverer on 2 registered patents arising from research.